Skip to main content

Table 1 Clinical characteristics of HT patients and normal controls

From: Identification of BTK as an immune-related biomarker for Hashimoto’s thyroiditis by integrated bioinformatic analysis

Variables

HT

NC

Range

P-value

Number

24

20

-

-

Gender (M/F)

9/15

7/13

-

-

Age (year)

53 ± 16

46 ± 12

-

0.126

FT3 (pmol/liter)

4.83 ± 0.76

4.95 ± 0.56

3.28–6.47

0.538

FT4 (pmol/ liter)

9.36 ± 2.67

9.66 ± 1.28

7.64–16.03

0.646

TSH (uIU/ml)

8.90 ± 12.74

2.27 ± 1.13

0.56–5.91

0.024

TgAb (IU/ml)

244.55 ± 299.99

0.20 ± 0.20

0–4

< 0.001

TPOAb (IU/ml)

888.89 ± 1746.14

0.97 ± 1.03

0–9

< 0.001

  1. HT: hashimoto’s thyroiditis; NC: normal control; M: male; F: female; FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid-stimulating hormone; TgAb, anti-thyroglobulin antibody; TPOAb, anti-thyroid peroxidase antibody. Data correspond to the arithmetic mean ± SD